These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 28287001)

  • 1. Transplacental passage of vancomycin.
    Towers CV; Weitz B
    J Matern Fetal Neonatal Med; 2018 Apr; 31(8):1021-1024. PubMed ID: 28287001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplacental passage of vancomycin from mother to neonate.
    Onwuchuruba CN; Towers CV; Howard BC; Hennessy MD; Wolfe L; Brown MS
    Am J Obstet Gynecol; 2014 Apr; 210(4):352.e1-352.e4. PubMed ID: 24679944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplacental passage of clindamycin from mother to neonate.
    Wear CD; Towers CV; Brown MS; Weitz B; Porter S; Wolfe L
    J Perinatol; 2016 Nov; 36(11):960-961. PubMed ID: 27490192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplacental passage of vancomycin in noninfected term pregnant women.
    Laiprasert J; Klein K; Mueller BA; Pearlman MD
    Obstet Gynecol; 2007 May; 109(5):1105-10. PubMed ID: 17470590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transplacental passage of vancomycin during the second trimester of pregnancy.
    Bourget P; Fernandez H; Delouis C; Ribou F
    Obstet Gynecol; 1991 Nov; 78(5 Pt 2):908-11. PubMed ID: 1923224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transplacental passage of commonly used intrapartum antibiotics and its impact on the newborn management: A narrative review.
    Viel-Theriault I; Fell DB; Grynspan D; Redpath S; Thampi N
    Early Hum Dev; 2019 Aug; 135():6-10. PubMed ID: 31177037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inappropriate use of vancomycin for preventing perinatal group B streptococcal (GBS) disease in laboring patients.
    Peláez LM; Gelber SE; Fox NS; Chasen ST
    J Perinat Med; 2009; 37(5):487-9. PubMed ID: 19492913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplacental passage of vancomycin in the ex vivo human perfusion model.
    Hnat MD; Gainer J; Bawdon RE; Wendel GD
    Infect Dis Obstet Gynecol; 2004 Jun; 12(2):57-61. PubMed ID: 15739818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin dosage for group B streptococcus prophylaxis.
    Tse H; Wong SC; Sridhar S
    Am J Obstet Gynecol; 2014 Nov; 211(5):573-4. PubMed ID: 24954658
    [No Abstract]   [Full Text] [Related]  

  • 10. Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations.
    Prescrire Int; 2011 Mar; 20(114):72-7. PubMed ID: 21648230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
    Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
    Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of group B streptococcal disease in the newborn.
    Apgar BS; Greenberg G; Yen G
    Am Fam Physician; 2005 Mar; 71(5):903-10. PubMed ID: 15768620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic resistance patterns among group B Streptococcus isolates: implications for antibiotic prophylaxis for early-onset neonatal sepsis.
    Capanna F; Emonet SP; Cherkaoui A; Irion O; Schrenzel J; Martinez de Tejada B
    Swiss Med Wkly; 2013; 143():w13778. PubMed ID: 23572445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of vancomycin dosing for complicated infections in pediatric patients.
    Durham SH; Simmons ML; Mulherin DW; Foland JA
    Hosp Pediatr; 2015 May; 5(5):276-81. PubMed ID: 25934812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
    Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
    Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploration of optimal dosing regimens of vancomycin in patients infected with methicillin-resistant Staphylococcus aureus by modeling and simulation.
    Lim HS; Chong YP; Noh YH; Jung JA; Kim YS
    J Clin Pharm Ther; 2014 Apr; 39(2):196-203. PubMed ID: 24428720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Culture and Real-Time PCR Based Maternal Screening and Antibiotic Susceptibility for Group B Streptococcus: An Iranian Experience.
    Goudarzi G; Ghafarzadeh M; Shakib P; Anbari K
    Glob J Health Sci; 2015 Apr; 7(6):233-9. PubMed ID: 26153188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the pharmacodynamic profile of commonly used intravenous vancomycin dosing schemes in patients on automated peritoneal dialysis.
    Cardone KE; Chen WZ; Grabe DW; Batzold A; Manley HJ; Lodise TP
    J Antimicrob Chemother; 2014 Jul; 69(7):1873-6. PubMed ID: 24722842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease.
    Stafford IA; Stewart RD; Sheffield JS; Wendel GD; Sanchez PJ; McIntire DD; Roberts SW
    Obstet Gynecol; 2012 Jul; 120(1):123-9. PubMed ID: 22914400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.